In the milieu of 6-OHDA PD models, Icariin champions the Nrf2/HO-1 pathway, enriching the release of Keap1, HO-1, and NQO1, thus shielding against oxidative stress. This evidence concerns the gene NFE2L2 and Parkinson disease.